AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 196 filers reported holding AURINIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $253,434 | -11.9% | 32,617 | +9.8% | 0.00% | – |
| Q2 2023 | $287,661 | +5.4% | 29,717 | +19.3% | 0.00% | – |
| Q1 2023 | $272,992 | +149.4% | 24,908 | -1.7% | 0.00% | – |
| Q4 2022 | $109,464 | -44.2% | 25,339 | -3.0% | 0.00% | – |
| Q3 2022 | $196,000 | -26.6% | 26,120 | -1.6% | 0.00% | – |
| Q2 2022 | $267,000 | -25.4% | 26,543 | -8.3% | 0.00% | – |
| Q1 2022 | $358,000 | -39.5% | 28,943 | +11.8% | 0.00% | – |
| Q4 2021 | $592,000 | +49.1% | 25,883 | +44.2% | 0.00% | – |
| Q3 2021 | $397,000 | +39.3% | 17,954 | -18.4% | 0.00% | – |
| Q2 2021 | $285,000 | +55.7% | 21,990 | +56.0% | 0.00% | – |
| Q1 2021 | $183,000 | +2.8% | 14,093 | +9.2% | 0.00% | – |
| Q4 2020 | $178,000 | -14.8% | 12,903 | -57.0% | 0.00% | -100.0% |
| Q1 2017 | $209,000 | – | 30,002 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blackcrane Capital, LLC | 503,248 | $6,535,000 | 10.30% |
| Prosight Management, LP | 360,834 | $4,685,000 | 3.84% |
| Healthcare Value Capital, LLC | 100,000 | $1,299,000 | 2.89% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,748,208 | $22,700,000 | 2.32% |
| DG Capital Management, LLC | 591,154 | $7,676,000 | 1.83% |
| NEA Management Company, LLC | 5,172,683 | $67,193,000 | 1.51% |
| Altium Capital Management LP | 408,908 | $5,310,000 | 1.47% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 170,316 | $2,212,000 | 1.17% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 298,500 | $3,875,000 | 1.02% |
| KNOTT DAVID M | 154,840 | $2,011,000 | 0.86% |